Updating results

Social care

A quick guide to NICE resources for social care

Published November 2019 Last updated November 2019

Topic selection

How we select the subjects for development into information, advice and guidance

Published November 2019 Last updated November 2019

Point-of-care creatinine devices to assess kidney function before CT imaging with intravenous contrast (DG37)

Evidence-based recommendations on point-of-care creatinine devices to assess kidney function before CT imaging with intravenous contrast

Diagnostics guidance Published November 2019

Rapid tests for group A streptococcal infections in people with a sore throat (DG38)

Evidence-based recommendations on rapid tests for group A streptococcal (strep A) infections in people aged 5 and over with a sore throat

Diagnostics guidance Published November 2019

NICE technology appraisal guidance

Technology appraisals are recommendations on the clinical and cost-effectiveness of medicines and treatments in the NHS.

Published November 2019 Last updated November 2019

Jobs

Jobs at NICE. Includes current vacancies, roles, location and salary information.

Published November 2019 Last updated November 2019

Rucaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer (TA611)

Evidence-based recommendations on rucaparib (Rubraca) for relapsed platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer that has responded to

Technology appraisal guidance Published November 2019

Pentosan polysulfate sodium for treating bladder pain syndrome (TA610)

Evidence-based recommendations on pentosan polysulfate sodium (Elmiron) for bladder pain syndrome in adults

Technology appraisal guidance Published November 2019

Board interests register

Outside interests of the NICE board

Published November 2019 Last updated November 2019

Resource planner (formerly known as the forward planner)

Our tool to help you plan for and implement NICE guidance. View upcoming guidance and understand the impact of guidance on your resources. Previously known as the forward planner.

Published November 2019 Last updated November 2019

Data collection agreement

This agreement relates to: Tezacaftor and ivacaftor (Symkevi®) in combination with ivacaftor (kalydeco) for treating cystic fibrosis patients who are

Published November 2019 Last updated November 2019

Highly Specialised Technologies Evaluation Committee

NICE recommendations on the use of highly specialised technologies are made by an independent advisory committee called the Highly Specialised...

Published November 2019 Last updated November 2019

Physiotherapy Low Back Pain Drop-in Services

Shared learning Published February 2011

NICE during the pre-election period

As a public body, NICE is required to follow civil service principles on communicating during the lead up to the general election.

News Published November 2019 Last updated November 2019

Endorsement

Formally endorses resources produced by external organisations that support the implementation of NICE guidance and the use of quality standards.

Published November 2019 Last updated November 2019

Medical Technologies Advisory Committee members

Find out more about the NICE Medical Technologies Advisory Committee members by reading their biographies. Professor Peter Groves Chair About

Published November 2019 Last updated November 2019

Quality Standards Advisory Committee 3 members

Find out more about quality standards advisory committee 3 members at NICE.

Published November 2019 Last updated November 2019

Acute kidney injury

Everything NICE has said on preventing, detecting and managing acute kidney injury in an interactive flowchart

NICE Pathway Published August 2013 Last updated November 2019

Ovarian cancer

Everything NICE has said on recognising and managing ovarian cancer in an interactive flowchart

NICE Pathway Published February 2012 Last updated November 2019

Urogenital conditions

Everything NICE has said on urogenital conditions in an interactive flowchart

NICE Pathway Published June 2015 Last updated November 2019

Excess winter deaths and illnesses associated with cold homes

Everything NICE has said on reducing the risk of excess winter deaths and illness associated with cold homes in an interactive flowchart

NICE Pathway Published March 2015 Last updated November 2019

Self-limiting respiratory tract and ear infections – antibiotic prescribing

Everything NICE has said on antibiotic prescribing for self-limiting respiratory tract and ear infections in primary care in an interactive flowchart

NICE Pathway Published August 2012 Last updated November 2019

East of England Stroke Telemedicine Stakeholder Partnership

Shared learning Published November 2019

Cannabis-based medicinal products

Everything NICE has said on cannabis-based medicinal products in an interactive flowchart.

NICE Pathway Published November 2019

Multiple sclerosis

Everything NICE has said on multiple sclerosis in an interactive flowchart

NICE Pathway Published October 2014 Last updated November 2019

Cannabis-based medicinal products (NG144)

This guideline covers prescribing of cannabis-based medicinal products for people with intractable nausea and vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy.

NICE guideline Published November 2019

Tailored Resources

We've produced resources to support our social care guidelines and quality standards. The resources contain key messages and are designed to help you...

Published November 2019 Last updated November 2019

Patient access schemes liaison unit

Patient access schemes and the NICE Patient Access Liaison Unit When assessing new drugs and treatments, NICE looks at the cost of the treatment and...

Published November 2019 Last updated November 2019

Multiple sclerosis in adults: management (CG186)

This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over. It aims to improve the quality of life for adults with multiple sclerosis by promoting symptom management, comprehensive reviews and effective relapse treatment.

Clinical guideline Published October 2014 Last updated November 2019

Helping to prevent winter deaths and illnesses associated with cold homes

A quick guide for home care managers on preventing deaths and illnesses associated with cold homes.

Published November 2019 Last updated November 2019

Moving between hospital and home, including care homes

NICE quick guide - moving between hospital and home, including care homes

Published November 2019 Last updated November 2019

Recognising and preventing delirium

A quick guide for care home managers Jump to: Risk factors Recognising delirium Preventing delirium Sharing information Further information

Published November 2019 Last updated November 2019

Better home care for older people

A quick and easy-to-read guide to the standard of care you should expect from a home care provider.

Published November 2019 Last updated November 2019

What is the optimal antibiotic prophylaxis regimen for women who are having a surgical abortion?

Recommendation ID NG140/1 Question What is the optimal antibiotic prophylaxis regimen for women who are having a surgical abortion?

Research recommendation Published November 2019

Should women having a surgical abortion up to and including 10+0 weeks' gestation have anti-D prophylaxis if they are RhD (or D) negative?

Recommendation ID NG140/3 Question Should women having a surgical abortion up to and including 10+0 weeks' gestation have anti-D prophylaxis

Research recommendation Published November 2019

What are the most effective and acceptable methods of cervical priming before dilatation and evacuation after 16+0 weeks' gestation?

Recommendation ID NG140/2 Question What are the most effective and acceptable methods of cervical priming before dilatation and evacuation

Research recommendation Published November 2019

Which people with extreme hypertension (220/120 mmHg or higher) or emergency symptoms should be referred for same-day hospital specialist assessment?

Recommendation ID NG136/6 Question Which people with extreme hypertension (220/120 mmHg or higher) or emergency symptoms should be referred

Research recommendation Published November 2019

What is the most accurate prenatal screening marker for TAPS, including middle cerebral artery peak systolic velocity (MCA‑PSV)?

Recommendation ID NG137/1 Question What is the most accurate prenatal screening marker for TAPS, including middle cerebral artery peak systolic

Research recommendation Published November 2019

What is the optimal regimen for general anaesthesia for women having surgical abortion?

Recommendation ID NG140/7 Question What is the optimal regimen for general anaesthesia for women having surgical abortion? Any explanatory

Research recommendation Published November 2019

What local anaesthetic techniques are most effective for women having surgical abortion?

Recommendation ID NG140/5 Question What local anaesthetic techniques are most effective for women having surgical abortion? Any explanatory

Research recommendation Published November 2019

For women who are having medical abortion between 10+1 and 12+0 weeks, what is the efficacy and acceptability of expulsion at home compared with expulsion in a clinical setting?

Recommendation ID NG140/4 Question For women who are having medical abortion between 10+1 and 12+0 weeks, what is the efficacy and acceptability

Research recommendation Published November 2019

Apart from culture, what other diagnostic tests or combinations of tests are effective inestablishing an accurate diagnosis of active respiratory TB in children and young people withsuspected active TB?

Recommendation ID NG33/2 Question Apart from culture, what other diagnostic tests or combinations of tests are effective inestablishing

Research recommendation Published November 2019

What effects does isolation have on the quality of life of people being treated for TB?

Recommendation ID NG33/4 Question What effects does isolation have on the quality of life of people being treated for TB? Any explanatory

Research recommendation Published November 2019

What is the effectiveness and safety of regimens using mifepristone and misoprostol for women who are having medical abortion after 23+6 weeks' gestation, particularly for those who have had a previous caesarean section or uterine surgery?

Recommendation ID NG140/6 Question What is the effectiveness and safety of regimens using mifepristone and misoprostol for women who are

Research recommendation Published November 2019

For isoniazid-resistant TB, what is the most effective regimen for reducing mortality andmorbidity?

Recommendation ID NG33/3 Question For isoniazid-resistant TB, what is the most effective regimen for reducing mortality andmorbidity?

Research recommendation Published November 2019

For people with active, drug susceptible TB who experience treatment interruptions because of adverse events, particularly hepatotoxicity, what approach to re-establishing treatment is mosteffective in reducing mortality and morbidity?

Recommendation ID NG33/5 Question For people with active, drug susceptible TB who experience treatment interruptions because of adverse

Research recommendation Published November 2019

In people with suspected TB, what is the relative clinical and cost effectiveness of universal andrisk-based use of rapid nucleic acid amplification tests?

Recommendation ID NG33/1 Question In people with suspected TB, what is the relative clinical and cost effectiveness of universal andrisk-based

Research recommendation Published November 2019